Simplex Trading’s Apyx Medical APYX Stock Holding History

Simplex Trading’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,900	Closed	-$14.4K	–	9234
2026 Q1	$14.4K	Buy	3,900 +2,500	+179%	+$9.34K	﹤0.01%	7031
2025 Q4	$4.9K	Buy	+1,400	New	+$4.88K	﹤0.01%	7441
2025 Q2	–	Sell	-1,000	Closed	-$1K	–	8560
2025 Q1	$1K	Sell	1,000 -4,500	-82%	-$6.2K	﹤0.01%	8137
2024 Q4	$8K	Buy	+5,500	New	+$7.69K	﹤0.01%	7302
2023 Q3	–	Sell	-700	Closed	-$3K	–	8591
2023 Q2	$3K	Buy	+700	New	+$3.55K	﹤0.01%	8170
2021 Q2	–	Sell	-290	Closed	-$280K	–	9978
2021 Q1	$280K	Buy	+290	New	+$2.9K	﹤0.01%	4223

Other funds holding APYX

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Simplex Trading's APYX Position: Q2 2026 in Review

Simplex Trading reduced its Apyx Medical (APYX) stake by 61% in Q2 2026, selling an estimated $17.9K and leaving 2,867 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7484.

Simplex Trading first reported a position in APYX in Q3 2018 and has held it in 24 quarters since. The position peaked at $179K in Q4 2018. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

Simplex Trading held 2,867 shares of Apyx Medical worth $12.9K as of Q2 2026.
Simplex Trading sold 4,525 Apyx Medical shares in Q2 2026, an estimated $17.9K.
Apyx Medical made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7484 holding.
Simplex Trading first reported a position in Apyx Medical in Q3 2018 and has held it in 24 quarters since.
Simplex Trading's Apyx Medical position peaked at $179K in Q4 2018.
68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.